中药内调外敷治疗老年性带状疱疹临床的研究.docVIP

中药内调外敷治疗老年性带状疱疹临床的研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
中药内调外敷治疗老年性带状疱疹临床的研究

PAGE \* MERGEFORMAT 1 中药内调外敷治疗老年性带状疱疹临床研究【摘要】 目的 观察中药内调与外敷相结合治疗老年性带状疱疹的疗效,从循证医学角度对其进行疗效评估。方法 采用随机、开放、阳性药平行对照的试验方法,将符合入选标准的156例患者随机分为观察组和对照组(各78例)。观察组给予中药内调配合外敷,对照组给予阿昔洛韦、聚肌胞。均以10 d为1个观察周期。结果 观察组总有效率(98.70%)高于对照组(84.62%),2组比较差异显著(Plt;0.05);观察组症状改善(止疱、结痂、止痛)优于对照组(Plt;0.05),视觉模拟评分(VAS)积分值优于对照组(Plt;0.05);观察组后神经痛的发生率(2.60%)低于对照组(39.7%),免疫球蛋白(IgM、IgG、IgA)下调幅度优于对照组(Plt;0.05),T淋巴细胞亚群CD3+、CD4+、CD4+/CD8+上调幅度优于对照组(Plt;0.05);CD8+下调幅度优于对照组(Plt;0.05)。循证医学临床价值评估:OR=6.82,95%CI=1.60~29.089;RR=0.17, 95%CI=0.04~0.73;RRR=83.0%,95%CI=27.0%~96.0%;ARR=12.8%,95%CI=4.00%~13.68%;NNT=8,95%CI=4~25(例)。结论 中药内外合治法治疗老年性带状疱疹疗效好,可有效预防带状疱疹治愈后的后遗神经痛,并可调节老年性带状疱疹患者的免疫功能。 【关键词】 外敷疗法;中医药疗法;阿昔洛韦;带状疱疹 Abstract:Objective To observe the therapeutic effect of Chinese medicine in treating elderly herpes zoster, and study the clinical evaluation of the treatment with Chinese medicine from evidence-based medicine (EBM) view. Methods All the 156 elderly patients diagnosed with herpes zoster were randomly divided into treatment group (78) and control group (78). The former group was administered with Chinese medicine by oral administration and topical application, while the latter took aciclovir alone. All the case were treated for 10 days. Results The overall response rates of Chinese medicine and aciclovir in treatment herpes zoster were respectively 98.70% and 84.62% (Plt;0.05). Symptoms improvement (controlling herpes, crust and pain), VAS points, the descent degree of Ig and CD8+, the ascent degree of CD3+、CD4+、CD4+/CD8+ of treatment group were significantly better than that in control group (Plt;0.05). The incidence of PHN of treatment groups was lesser than that of control group (2.60% and 39.7% respectively). Statistics of EBM:odds ration (OR) was 6.82 with 95% confidence interval (CI) from 1.60 to 29.087;relative risk (RR) was 0.17 wirh 95%CI from 0.04 to 0.73;relative risk reduction (RRR) was 83.0% with 95%CI from 27.0% to 96.0%;absolute risk reduction (ARR) was 12.8% with 95%CI from 4.00% to 13.68%;

文档评论(0)

fangsheke66 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档